Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease
Recruiting
Observational Study
Chronic Obstructive Pulmonary Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 180 (estimated)
- Sponsor
- Fu Jen Catholic University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* pre-COPD or COPD stages I-IV as per the 2023 GOLD guidelines (case group)
* healthy individuals without chronic diseases or major medical conditions
Exclusion Criteria:
* diagnosed with neuromuscular diseases
* experienced respiratory disease exacerbation requiring emergency…
Contacts